Activin A as a marker of intrauterine infection in women with preterm prelabour rupture of membranes

Journal of Perinatology

Volumn 30, Issue 1, 2010, Pages 22-26

  Hodges, R ^a   Salvador, L ^b   D'Antona, D ^b   Georgiou, H M ^c   Wallace, E M ^a  

^a HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF PADOVA   (Italy)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Activin; Chorioamnionitis; Intrauterine infection

Indexed keywords

ACTIVIN A; BETAMETHASONE; C REACTIVE PROTEIN; ERYTHROMYCIN; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DELIVERY; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GESTATION PERIOD; HUMAN; INFANT; INTRAUTERINE INFECTION; LEUKOCYTE COUNT; MATERNAL BLOOD; MEDICAL ASSESSMENT; MEDICAL RECORD REVIEW; PREGNANCY; PREGNANCY OUTCOME; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURE LABOR;

ACTIVINS; ADULT; BIOLOGICAL MARKERS; CHORIOAMNIONITIS; FEMALE; FETAL MEMBRANES, PREMATURE RUPTURE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PROSPECTIVE STUDIES;

EID: 76849091338     PISSN: 07438346     EISSN: 14765543     Source Type: Journal    
DOI: 10.1038/jp.2009.109     Document Type: Article

References (34)

1. Goldenburg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth. Lancet 2008; 371: 75-84.
2. Gaudet L, Smith GN. Cerebral Palsy and chorioamnionitis: the inflammatory cytokine link. Obstet Gynecol Surv 2001; 56: 433-436.
3. Wu YW, Coleford JM. Chorioamnionitis as a risk factor for cerebral palsy: a meta-analysis. JAMA 2000; 284: 1417-1424.
4. Lieman JM, Brumfield CG, Carlo W, Ramsey PS. Preterm premature rupture of membranes: is there an optimal gestational age for delivery? Obstet Gynecol 2005; 105: 12-17.
5. Locatelli A, Ghidini A, Paterlini G, Patanè L, Doria V, Zorloni C et al. Gestational age at preterm premature rupture of membranes: a risk factor for neonatal white matter damage. Am J Obstet Gynecol 2005; 193: 947-951.
6. Buchanan S, Crowther C, Morris J. Preterm prelabour rupture of membranes: a survery of current practice. Aust NZ J Obstet Gynaecol 2004; 43: 400-403.
7. Royal College of Obstetricians and Gynaecologists. Preterm prelabour rupture of the membranes. RCOG Guideline No.44 2006 www.rcog.org.uk uk/index.asp? PageID=1813. Last accessed 19/12/08).
8. Carroll SG, Papaioannou S, Davies ET, Nicolaides KH. Maternal assessment in the prediction of intrauterine infection in preterm prelabor amniorrhexis. Fetal Diagn Ther 1995; 10: 290-296.
9. Yoon BH, Jun JK, Park KH. Serum C-reactive protein, white blood cell count, and amniotic fluid white blood cell count in women with preterm premature rupture of membranes. Obstet Gynecol 1996; 88: 1034-1040.
10. Trochez-Martinez RD, Smith P, Lamont RF. Use of C-reactive protein as a predictor of chorioamnionitis in preterm prelabour rupture of membranes: a systematic review. Br J Obstet Gynaecol 2007; 114: 796-801.
11. Denison FC, Elliott CL, Wallace EM. Dexamethasone-induced leucocytosis in pregnancy. Br J Obstet Gynaecol 1997; 104: 851-853.
12. Wallace EM, Ekkel K, Cotter T, Tippett C, Catalano J. Haematological effects of betamethasone treatment in late pregnancy. Aust NZ J Obstet Gynaecol 1998; 38: 396-398.
13. Del Valle GO, Joffe GM, Izquierdo LA, Smith JF, Gilson GJ, Curet LB. The biophysical profile and the nonstress test: poor predictors of chorioamnionitis and fetal infection in prolonged preterm premature rupture of membranes. Obstet Gynecol 1992; 80: 106-110.
14. Tong S, Wallace EM, Burger HG. Inhibins and activins: clinical advances in reproductive medicine. Clin Endocrinol 2003; 58: 115-127.
15. Wallace EM, Healy DL. Inhibins and activins: roles in clinical practice. Br J Obstet Gynaecol 1996; 103: 945-956.
16. Wallace EM, Riley SC, Crossley JA, Ritoe SC, Horne A, Shade M et al. Dimeric inhibins in amniotic fluid, maternal serum and fetal serum in human pregnancy. J Clin Endocrinol Metab 1997; 82: 218-222.
17. Riley SC, Balfour C, Wathen NC, Groome NP, Wallace EM. Inhibins in extra-embryonic coelomic and amniotic fluids and maternal serum in early pregnancy. Hum Reprod 1996; 11: 2722-2776.
18. Wallace EM, Schneider-Kolsky M, Thirunavukarasu P. Activin A, inhibin A, inhibin B and parturition: changes of maternal and cord serum levels according to the mode of delivery. Br J Obstet Gynaecol 2000; 107: 704-705.
19. Florio P, Severi FM, Bocchi C, Luisi S, Petraglia F. Abruptio placentae and highest maternal serum activin A levels at mid-gestation: a two cases report. Placenta 2003; 24: 279-280.
20. Muttukrishna S, Knight PG, Groome NP. Activin A and inhibin A as possible endocrine markers of pre-eclampsia. Lancet 1997; 349: 1285-1288.
21. D'Antona D, Reis FM, Benedetto C, Evans LW, Groome NP, de Kretser DM et al. Increased maternal serum activin A but not follistatin levels in pregnant women with hypertensive disorders. J Endocrinol 2000; 165: 157-162.
22. Manuelpillai U, Schneider-Kolsky M, Dole A, Wallace EM. Activin A and activin receptors in gestational tissue from preeclamptic pregnancies. J Endocrinol 2001; 171: 57-64.
23. Mandang S, Manuelpillai U, Wallace EM. Oxidative stress increases placental and endothelial cell activin A secretion. J Endocrinol 2007; 192: 485-493.
24. Barkehall-Thomas A, Tony S, Baker LS, Edwards A, Wallace EM. Maternal serum activin A and the prediction of intrauterine growth restriction. Aust NZ J Obstet Gynaecol 2006; 46: 97-101.
25. Wallace EM, Schneider-Kolsky ME, Edwards A, Baker L, Jenkin G. Maternal seum activin A levels in association with intrauterine fetal growth restriction. Br J Obstet Gynaecol 2003; 110: 306-310.
26. Petraglia F, Di Blasio AM, Florio P, Gallo R, Genazzani AR, Woodruff TK et al. High levels of fetal membrane activin beta A and activin receptor IIB mRNAs and augmented concentration of amniotic fluid activin A in women in term and preterm labor. J Endocrinol 1997; 154: 95-101.
27. Keelan JA, Zhou RL, Evans LW. Regulation of activin A, inhibin A, and follistatin production in human amnion and choriodecidual explants by inflammatory mediators. J Soc Gynecol Investig 2000; 7: 291-296.
28. Phillips DJ, Jones KL, Scheerlinck JY, Hedger MP, de Kretser DM. Evidence for activin A and follistatin involvement in the systemic inflammatory response. Mol Cell Endocrinol 2001; 180: 155-162.
29. Jones KL, de Kretser DM, Patella S, Phillips DJ. Activin A and follistatin in systemic inflammation. Mol Cell Endocrinol 2004; 225: 119-125.
30. Jones KL, Brauman JN, Groome NP, de Kretser DM, Phillips DJ. Activin A release into the circulation is an early event in systemic inflammation and precedes the release of follistatin. Endocrinology 2000; 141: 1905-1908.
31. Redline RW, Faye-Petersen O, Heller D, Qureshi F, Savell V, Vogler C. Society for Pediatric Pathology, Perinatal Section, Amniotic Fluid Infection Nosology Committee. Amniotic infection syndrome: nosology and reproducibility of placental reaction patterns. Pediatr Dev Pathol 2003; 6: 435-448.
32. Riley SC, Balfour C, Wathen NC, Chard T, Evans LW, Groome NP et al. Follistatin and activin-A in extra-embryonic coelomic and amniotic fluids and maternal serum in early pregnancy. Hum Reprod 1998; 13: 2624-2628.
33. Coleman MA, France JT, Schellenberg JC, Ananiev V, Townend K, Keelan JA et al. Corticotropin-releasing hormone, corticotropin-releasing hormone binding protein, and activin-A in maternal serum: prediction of preterm delivery and response to glucocorticoids in women with symptoms of pteterm labour. Am J Obstet Gynecol 2000; 183: 645-648.
34. Murtha AP, Sinclair T, Hauser ER, Swamy GK, Herbert WN, Heine RP. Maternal serum cytokines in preterm premature rupture of membranes. Obstet Gynecol 2007; 109: 121-127.